References
- Kannel W B. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis 1974; 7: 5–24
- Hansson L, Dahlöf B. What are we really achieving with long-term antihypertensive drug therapy?. Hypertension: pathophysiology, diagnosis, and management, J H Laragh, B M Brenner. Raven Press, New York 1990; 2131–41
- Collins R, Peto R, Mac Mahon S, et al. Blood pressure, stroke, and coronary heart disease. Lancet 1990; 335: 827–38
- Hansson L. What are we really achieving with long-term drug therapy?. Am J Hypertens 1988; 1: 414–20
- Lindholm L, Ejlertsson G, Scherstén B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40–59-year-old hypertensives in a Swedish primary care district. Acta Med Scand 1984; 21: 251–9
- Samuelsson O. Hypertension in middle-aged men: management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand 1985; 218(Suppl 702)1–79
- Isles C G, Walker L M, Beevers D G, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141–56
- Mc Stewart I DG. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979; i: 861–5
- Cruickshank J M, Thorp J M, Zacharias F J. Benefits and potential harm of lowering high blood pressure. Lancet 1987; i: 581–4
- Alderman M H, Ooi W L, Madhavan S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989; 262: 920–4
- Hansson L. Editorial: how far should blood pressure be lowered? What is the role of the J-curve?. Am J Hypertens 1990; 3: 726–9
- The BBB Study Group. The BBB Study: a prospective randomized study of intensified antihypertensive treatment. J Hypertens 1988; 6: 693–7
- Hansson L for the BBB Study Group. Reduction in blood pressure and adverse effects in the BBB Study. Presented at the 5th European Society of Hypertension meeting, Milan, June, 1991, (Abstract)
- Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded End-point (PROBE) study: a novel design for intervention trials. Blood Pressure 1992; 1: 113–9
- The HOT Study Group. The Hypertension Optimal Treatment (HOT) Study—A prospective study of the optimal therapeutic goal and of the value of low-dose aspirin in antihypertensive treatment. Blood Pressure 1993; 2: 62–8